Impact of daily lifestyle on coronary heart disease

Wan,Yan‑Fang; Ma,Xiao‑Li; Yuan,Chen; Fei,Ling; Yang,Jing; Zhang,Jun

doi:10.3892/etm.2015.2646

Impact of daily lifestyle on coronary heart disease

Authors:
- Yan‑Fang Wan
- Xiao‑Li Ma
- Chen Yuan
- Ling Fei
- Jing Yang
- Jun Zhang
View Affiliations

Affiliations: Department of Cardiology, Cangzhou Central Hospital, Hebei Medical University, Cangzhou, Hebei 061001, P.R. China
Published online on: July 17, 2015 https://doi.org/10.3892/etm.2015.2646
Pages: 1115-1120

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Limited data are available with regard to the impact of daily lifestyle choices in patients with coronary heart disease (CHD) who have undergone stent placement. Thus, the aim of the present study was to investigate the impact of daily lifestyle factors in patients with CHD following stent implantation. Between March 2005 and March 2006, 129 consecutive patients with CHD were admitted to Cangzhou Central Hospital at Hebei Medical University (Cangzhou, China). The patients underwent coronary stenting and participated in a 7‑year clinical follow‑up that analyzed the impact of their daily lifestyle choices on CHD following the stent placement. Rates of dinner satiety [95% confidence interval (CI), 1.121‑10.97, P=0.005], smoking (95% CI, 4.05‑34.90, P=2.01x10‑7) and heavy alcohol use (95% CI, 1.32‑11.05, P=0.006) were significantly higher in the repeated (re)‑revascularization group when compared with the non‑revascularization group. In addition, the exercise rate was significantly lower in the re‑revascularization group when compared with the non‑revascularization group (95% CI, 0.02‑0.65, P=0.005). However, no statistically significant differences were observed between the groups with regard to sleeping patterns (95% CI, 0.03‑0.71, P=0.270) or anxiety rates (P=0.289). A coronary angiography performed during re‑revascularization revealed in‑stent restenosis in 26% of the patients, stenoses at the entrance to or exit from the stent in 29% of the patients and new lesions in 19% of the patients. Furthermore, original lesions exhibited deterioration in 26% of the patients. The clinical endpoint was reached in 55% of the patients between 3 and 5 years of the follow‑up period. In conclusion, poor daily lifestyle habits can increase the in‑stent restenosis rate, accelerate the progression of the original lesion and promote the emergence of new lesions in patients with CHD following stent placement.

View Figures

View References

1	He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med. 353:1124–1134. 2005. View Article : Google Scholar : PubMed/NCBI
2	Biondi Zoccai G, Abbate A, D'Ascenzo F, et al: Percutaneous coronary intervention in nonagenarians: pros and cons. J Geriatr Cardiol. 10:82–90. 2013.PubMed/NCBI
3	Bangalore S, Gupta N, Guo Y and Feit F: Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions. Int J Cardiol. 175:108–119. 2014. View Article : Google Scholar : PubMed/NCBI
4	Giacoppo D, Baber U and Mehran R: Current developments in dual antiplatelet therapy after stenting. Minerva Cardioangiol. 62:261–276. 2014.PubMed/NCBI
5	Nöthlings U, Ford ES, Kröger J and Boeing H: Lifestyle factors and mortality among adults with diabetes: Findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam study. J Diabetes. 2:112–117. 2010. View Article : Google Scholar : PubMed/NCBI
6	Hu FB, Liu Y and Willett WC: Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev. 12:552–559. 2011. View Article : Google Scholar : PubMed/NCBI
7	Reddy P, Rankins D, Timoshanko A and Dunbar JA: Life! in Australia: translating prevention research into a large-scale intervention. Br J Diabetes Vasc Dis. 11:193–197. 2011. View Article : Google Scholar
8	Krueger PM and Chang VW: Being poor and coping with stress: health behaviors and the risk of death. Am J Public Health. 98:889–896. 2008. View Article : Google Scholar : PubMed/NCBI
9	Menotti A, Puddu PE, Lanti M, Maiani G, Catasta G and Fidanza AA: Lifestyle habits and mortality from all and specific causes of death: 40-year follow-up in the Italian Rural Areas of the Seven Countries Study. J Nutr Health Aging. 18:314–321. 2014. View Article : Google Scholar : PubMed/NCBI
10	Smith SC Jr, Dove JT, Jacobs AK, et al: American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty: ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 37:2215–2239. 2001. View Article : Google Scholar : PubMed/NCBI
11	Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62. 1960. View Article : Google Scholar : PubMed/NCBI
12	Eisenstein EL, Anstrom KJ, Kong DF, et al: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 297:159–168. 2007. View Article : Google Scholar : PubMed/NCBI
13	Leproult R and Van Cauter E: Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev. 17:11–21. 2010. View Article : Google Scholar : PubMed/NCBI
14	Copinschi G: Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol. 6:341–347. 2005.PubMed/NCBI
15	Lespérance F, Frasure-Smith N, Théroux P and Irwin M: The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6 and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 161:271–277. 2004. View Article : Google Scholar : PubMed/NCBI
16	Sherwood A, Hinderliter AL, Watkins LL, Waugh RA and Blumenthal JA: Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 46:656–659. 2005. View Article : Google Scholar : PubMed/NCBI
17	Pizzi C, Manzoli L, Mancini S and Costa GM: Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation and endothelial function. Eur Heart J. 29:1110–1117. 2008. View Article : Google Scholar : PubMed/NCBI
18	Lucassen EA, Zhao X, Rother KI, et al: Sleep Extension Study Group: Evening chronotype is associated with changes in eating behavior, more sleep apnea, and increased stress hormones in short sleeping obese individuals. PLoS One. 8:e565192013. View Article : Google Scholar : PubMed/NCBI
19	Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B and Whooley MA: Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 217:503–508. 2011. View Article : Google Scholar : PubMed/NCBI
20	Rajendran K, Devarajan N, Ganesan M and Ragunathan M: Obesity, Inflammation and Acute Myocardial Infarction-Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population. Thromb J. 10:132012. View Article : Google Scholar : PubMed/NCBI
21	Knudson JD, Payne GA, Borbouse L and Tune JD: Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep. 10:434–439. 2008. View Article : Google Scholar : PubMed/NCBI
22	Elbatarny HS and Maurice DH: Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am J Physiol Endocrinol Metab. 289:E695–E702. 2005. View Article : Google Scholar : PubMed/NCBI
23	Hou X, Lu J, Weng J, et al: Chinese National Diabetes and Metabolic Disorders Study Group: Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS One. 8:e573192013. View Article : Google Scholar : PubMed/NCBI
24	Bays H and Dujovne C: Pharmacotherapy of obesity: currently marketed and upcoming agents. Am J Cardiovasc Drugs. 2:245–253. 2002. View Article : Google Scholar : PubMed/NCBI
25	Gu D, Kelly TN, Wu X, et al: Mortality attributable to smoking in China. N Engl J Med. 360:150–159. 2009. View Article : Google Scholar : PubMed/NCBI
26	Barua RS and Ambrose JA: Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol. 33:1460–1467. 2013. View Article : Google Scholar : PubMed/NCBI
27	Bliden KP, Dichiara J, Lawal L, et al: The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol. 52:531–533. 2008. View Article : Google Scholar : PubMed/NCBI
28	Klatsky AL, Armstrong MA and Friedman GD: Alcohol and mortality. Ann Intern Med. 117:646–654. 1992. View Article : Google Scholar : PubMed/NCBI
29	Emberson JR, Shaper AG, Wannamethee SG, Morris RW and Whincup PH: Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Am J Epidemiol. 161:856–863. 2005. View Article : Google Scholar : PubMed/NCBI
30	Goldberg DM, Hahn SE and Parkes JG: Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta. 237:155–187. 1995. View Article : Google Scholar : PubMed/NCBI
31	Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM and Hennekens CH: Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 100:944–950. 1999. View Article : Google Scholar : PubMed/NCBI
32	Guan Z, Lui CY, Morkin E and Bahl JJ: Oxidative stress and apoptosis in cardiomyocyte induced by high-dose alcohol. J Cardiovasc Pharmacol. 44:696–702. 2004. View Article : Google Scholar : PubMed/NCBI
33	O'Keefe JH, Bybee KA and Lavie CJ: Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol. 50:1009–1014. 2007. View Article : Google Scholar : PubMed/NCBI
34	Luk TH, Dai YL, Siu CW, et al: Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Eur J Prev Cardiol. 19:830–839. 2012. View Article : Google Scholar : PubMed/NCBI
35	Hedbäck B, Perk J, Hörnblad M and Ohlsson U: Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmissions to hospital. J Cardiovasc Risk. 8:153–158. 2001. View Article : Google Scholar : PubMed/NCBI
36	Yu CM, Lau CP, Chau J, McGhee S, Kong SL, Cheung BM and Li LS: A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention. Arch Phys Med Rehabil. 85:1915–1922. 2004. View Article : Google Scholar : PubMed/NCBI
37	Meng Khoo C and Tai ES: Trends in the incidence and mortality of coronary heart disease in asian pacific region: The Singapore experience. J Atheroscler Thromb. 21(Suppl 1): S2–S8. 2014. View Article : Google Scholar : PubMed/NCBI